BENZODIAZEPINE CONCENTRATIONS IN BRAIN DIRECTLY REFLECT RECEPTOR OCCUPANCY - STUDIES OF DIAZEPAM, LORAZEPAM, AND OXAZEPAM

被引:65
作者
GREENBLATT, DJ
SETHY, VH
机构
[1] TUFTS UNIV,SCH MED,DIV CLIN PHARMACOL,BOSTON,MA 02111
[2] UPJOHN CO,CNS DIS RES UNIT,KALAMAZOO,MI 49001
关键词
Benzodiazepines; Brain uptake; Pharmacokinetics; Receptor occupancy;
D O I
10.1007/BF02244106
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Groups of male CF-1 mice received 3 and 10 μmol/kg diazepam, lorazepam, and oxazepam intravenously. Between 1 min and 24 h after injection, benzodiazepine concentrations were determined by gas chromatography (GLC) in plasma and in one brain hemisphere; in the other hemisphere, ex vivo benzodiazepine receptor occupancy was measured using3H-flunitrazepam displacement. Based on GLC data, diazepam entered brain rapidly, and was also cleared rapidly, yielding desmethyldiazepam and oxazepam as metabolites in plasma and brain. However, lorazepam and oxazepam entered brain slowly, with brain:plasma equilibrium achieved at 30-60 min; thereafter, the drugs were eliminated from plasma and brain in parallel. The time course and extent of ex vivo occupancy were highly consistent with GLC data (for diazepam, GLC levels were expressed as the sum of diazepam, desmethyldiazepam, and oxazepam, with metabolite concentrations, normalized for molecular weight and for in vitro benzodiazepine receptor affinity.) Between-method correlations were 0.95 or higher. Thus benzodiazepine receptor occupancy is highly dependent on benzodiazepine concentrations in brain. Differences in the time-course of onset and duration of pharmacologic activity between the highly lipophilic benzodiazepine diazepam and the less lipophilic hydroxylated derivatives lorazepam and oxazepam are largely explained by differences in systemic kinetics and in the rate of uptake into brain. © 1990 Springer-Verlag.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 33 条
[1]   LORAZEPAM - A REVIEW OF ITS CLINICAL PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USES [J].
AMEER, B ;
GREENBLATT, DJ .
DRUGS, 1981, 21 (03) :161-200
[2]   DETERMINANTS OF BENZODIAZEPINE BRAIN UPTAKE - LIPOPHILICITY VERSUS BINDING-AFFINITY [J].
ARENDT, RM ;
GREENBLATT, DJ ;
LIEBISCH, DC ;
LUU, MD ;
PAUL, SM .
PSYCHOPHARMACOLOGY, 1987, 93 (01) :72-76
[3]  
ARENDT RM, 1983, J PHARMACOL EXP THER, V227, P95
[4]   DIAZEPAM AND LORAZEPAM FOR INTRAVENOUS SURGICAL PREMEDICATION [J].
CONNER, JT ;
KATZ, RL ;
BELLVILLE, JW ;
GRAHAM, C ;
PAGANO, R ;
DOREY, F .
JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 18 (5-6) :285-292
[5]  
ELLINWOOD EH, 1987, PSYCHOPHARMACOLOGY, V91, P168
[6]  
FRIEDMAN H, 1986, PSYCHOPHARMACOLOGY, V88, P267
[7]   RELATIVE AMNESIC ACTIONS OF DIAZEPAM, FLUNITRAZEPAM AND LORAZEPAM IN MAN [J].
GEORGE, KA ;
DUNDEE, JW .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 4 (01) :45-50
[8]   ENTRY OF DIAZEPAM AND ITS MAJOR METABOLITE INTO CEREBROSPINAL-FLUID [J].
GREENBLATT, DJ ;
OCHS, HR ;
LLOYD, BL .
PSYCHOPHARMACOLOGY, 1980, 70 (01) :89-93
[9]   DRUG-THERAPY - CLINICAL PHARMACOKINETICS .1. [J].
GREENBLATT, DJ ;
KOCHWESER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (14) :702-705
[10]   DRUG-THERAPY - CLINICAL PHARMACOKINETICS .2. [J].
GREENBLATT, DJ ;
KOCHWESER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (19) :964-970